CuraTeQ Biologics achieves milestone in Omalizumab biosimilar development

Pallavi Madhiraju- March 15, 2024 0

CuraTeQ Biologics Private Limited, a fully integrated arm of Aurobindo Pharma Ltd, has announced significant progress in its biosimilar program, revealing that its Omalizumab biosimilar ... Read More

FDA approves Genentech’s Xolair for food allergies: A new horizon in allergy treatment

Pallavi Madhiraju- February 17, 2024 0

The U.S. Food and Drug Administration (FDA) has approved Xolair (omalizumab) for reducing allergic reactions, including anaphylaxis, that may occur with accidental exposure to foods ... Read More